Back to videosWhile we wait for public orthopedic companies to announce 2025 second quarter results, we look the sluggish start to 2025, the changing competitive landscape and Globus Medical’s steady execution. Mike Evers is an analyst and writer with over 15 years of experience in the medical industry,...
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
